Gilead Sciences has been knocked back in its quest to bring the first drug therapy for hepatitis D virus (HDV) to the US market, after the FDA rejected its marketing application. News of the ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE registrational program. The ECLIPSE registrational program is designed to evaluate the ...

Hepatitis A and B are the most common vaccine-preventable diseases for travelers; nevertheless, up to 50% of confirmed cases of hepatitis A and B in Europe are still acquired during travel. [1 ...

There are five kinds of hepatitis. Each has different causes, with one commonality: Hepatitis causes your liver to get inflamed. Hepatitis disease can also sometimes be spread through sexual contact.